Showing results (131-140 of 281) with videos related to

Sort By:
Pageof 29
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanomaValerie P Grignol, Thomas Olencki, Kiran Relekar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 2016
A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ MelanomaJin-Qing Liu, Fatemeh Talebian, Lisha Wu, et al.
Annals of Surgical Oncology|October 22, 2023
The Implications of Racialized Economic Segregation and Allostatic Load on Mortality in Patients with Breast CancerJ C Chen, Demond Handley, Mohamed I Elsaid, et al.
Surgical Oncology|September 17, 2021
Characterization of inflammatory changes in the breast cancer associated adipose tissue and comparison to the unaffected contralateral breastAlecia M Blaszczak, Dionisia Quiroga, Anahita Jalilvand, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2003
Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinomaBrian D Badgwell, Daniel J Valentino, Edward B Jeffes, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010Gregory B Lesinski, William E Carson, Elizabeth A Repasky, et al.
Nature|July 3, 2008
Mouse development with a single E2F activatorShih-Yin Tsai, Rene Opavsky, Nidhi Sharma, et al.
Pageof 29